Clinical Trial Update: Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rapamycin combined with low-dose cytarabine in elderly patients with acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Low-dose cytarabine (Cytarabine (low-dose))
• Rapamycin (Sirolimus) (sirolimus)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED